Market Tracker

07/29 10:47am ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

6.46
Data as of 10:29am ET
 +0.23 / +3.69%
Today’s Change
5.40
Today|||52-Week Range
11.88
-12.58%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close6.23
Today’s open6.27
Day’s range6.25 - 6.50
Volume7,496
Average volume (3 months)82,491
Market cap$270.1M
Dividend yield--
Data as of 10:29am ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-84.69%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...+0.20+1.23%
SCMPSucampo Pharmaceutic...+0.07+1.16%
PPHMPeregrine Pharmaceut...+0.02+1.32%
IGIGI Laboratories Inc-0.01-0.20%
Data as of 10:45am ET, 07/29/2014

Financials

Next reporting dateAugust 12, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts